-
Founded in:
2000-10-20 -
Country:
China -
Address:
Chenglinzhuang Industrial Zone, Tianjin -
Tax NO.:
91120110103738323L -
Registered Funds:
- -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Carbamazepine |
Anticonvulsant, anti-epileptic, anti-neuropathic pain, anti-manic-depressive, improve symptoms of certain mental illnesses, anti-central diabetes insipidus. Possible mechanisms include: 1. Use-dependent blocking of various excitable cell membrane Na channels, so it can significantly inhibit the occurrence and spread of abnormal high-frequency discharges; 2. Inhibit T-type calcium channels; 3. Enhance the activity of central noradrenergic nerves; 4. Promote the secretion of antidiuretic hormone (ADH) or increase the sensitivity of effectors to ADH.
More
Anticonvulsant, anti-epileptic, anti-neuropathic pain, anti-manic-depressive, improve symptoms of certain mental illnesses, anti-central diabetes insipidus. Possible mechanisms include: 1. Use-dependent blocking of various excitable cell membrane Na channels, so it can significantly inhibit the occurrence and spread of abnormal high-frequency discharges; 2. Inhibit T-type calcium channels; 3. Enhance the activity of central noradrenergic nerves; 4. Promote the secretion of antidiuretic hormone (ADH) or increase the sensitivity of effectors to ADH. |
298-46-4 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Methocarbamol |
Extract from the above information
More
Extract from the above information |
532-03-6 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gliclazide |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
21187-98-4 | 23 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Furazolidone |
Extract from the above information
More
Extract from the above information |
67-45-8 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ticlopidine hydrochloride |
Antiplatelet aggregation drugs can inhibit platelet aggregation caused by various inducers such as ADP, collagen, thrombin, arachidonic acid and prostaglandin endoperoxides, and can inhibit platelet aggregation reactions induced by exogenous and endogenous ADP.
More
Antiplatelet aggregation drugs can inhibit platelet aggregation caused by various inducers such as ADP, collagen, thrombin, arachidonic acid and prostaglandin endoperoxides, and can inhibit platelet aggregation reactions induced by exogenous and endogenous ADP. |
53885-35-1 | 22 |